Roth Capital Upgrades Regeneron Pharma (REGN) to Neutral
Tweet
Share
E-mailGet Alerts REGN Hot Sheet
Price: $631.81 -0.17%
Rating Summary:
29 Buy, 19 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 14 | Down: 24 | New: 110
Rating Summary:
29 Buy, 19 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 14 | Down: 24 | New: 110
Join SI Premium – FREE
Roth Capital upgraded Regeneron Pharma (NASDAQ: REGN) from Buy to Neutral. PT $44.
For more ratings news on Regeneron Pharma click here and for the rating history of Regeneron Pharma click here.
Shares of Regeneron Pharma closed at $44.97 yesterday.
For more ratings news on Regeneron Pharma click here and for the rating history of Regeneron Pharma click here.
Shares of Regeneron Pharma closed at $44.97 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- BMO Capital Upgrades Casey's General Stores (CASY) to Outperform, 'Opportunity Knocks'
- UBS Upgrades Cytokinetics (CYTK) to Buy
- FDA selects 7 companies for domestic drug manufacturing pilot
Create E-mail Alert Related Categories
UpgradesRelated Entities
Roth CapitalSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
